(Q45295291)

English

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization

scientific article published on 3 January 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Eun Sun Jang

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Eun Ju Cho

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Su Jong Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Jeong-Hoon Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Yoon Jun Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Hyo-Suk Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Chung Yong Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

publication date

3 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

139

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

635-643

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Resectability of large focal liver lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Performance status assessment in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Infiltrating hepatocellular carcinoma: seeing the tree through the forest

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Chemoembolization in patients at high risk: results and complications.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transcatheter arterial chemo-lipiodol infusion for unresectable hepatocellular carcinoma in 96 high-risk patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoembolization of hepatocellular carcinoma: results of a metaanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical and pathological study of diffuse type hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-012-1364-2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45295291&oldid=2207192934"